Enacts provisions relating to insurance coverage for prescription insulin drugs

SB 1156 would require health insurance plans to cover prescription insulin with limited out-of-pocket costs for policyholders. It directly affects individuals with diabetes who rely on insulin, aiming to reduce their financial burden. The key provision would limit how much patients pay per insulin prescription, though specific cost thresholds aren't detailed in the abstract. The bill is pending review by the Senate Insurance and Banking Committee and has not yet been voted on. This legislation focuses on improving access to a critical medication through insurance coverage requirements.